Suppr超能文献

Infection with ibrutinib in patients with chronic lymphocytic leukemia: How strong is the association?

作者信息

Ball Somedeb, Vutthikraivit Wasawat, Maiti Abhishek, Short Nicholas J

机构信息

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Eur J Haematol. 2018 Sep;101(3):418-420. doi: 10.1111/ejh.13098. Epub 2018 Jun 22.

Abstract
摘要

相似文献

1
Infection with ibrutinib in patients with chronic lymphocytic leukemia: How strong is the association?
Eur J Haematol. 2018 Sep;101(3):418-420. doi: 10.1111/ejh.13098. Epub 2018 Jun 22.
3
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Future Oncol. 2020 Apr;16(10):517-523. doi: 10.2217/fon-2019-0844. Epub 2020 Mar 24.
4
Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib.
Leuk Lymphoma. 2019 Mar;60(3):842-844. doi: 10.1080/10428194.2018.1508673. Epub 2018 Sep 6.
6
Ibrutinib (Imbruvica) for chronic lymphocytic leukemia.
Med Lett Drugs Ther. 2014 Apr 14;56(1440):29-30.
7
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
Br J Haematol. 2018 Jan;180(2):301-304. doi: 10.1111/bjh.14322. Epub 2016 Sep 21.
8
Rapid flare of immune thrombocytopenia after stopping ibrutinib in a patient with chronic lymphocytic leukemia.
Leuk Lymphoma. 2018 Jul;59(7):1738-1741. doi: 10.1080/10428194.2017.1387907. Epub 2017 Oct 30.
9
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies.
Blood Adv. 2019 Jun 25;3(12):1799-1807. doi: 10.1182/bloodadvances.2018028761.
10
Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib.
Leuk Lymphoma. 2017 Feb;58(2):498-500. doi: 10.1080/10428194.2016.1182163. Epub 2016 Oct 18.

引用本文的文献

1
The Use of Bruton's Tyrosine Kinase Inhibitors to Treat Allergic Disorders.
Curr Treat Options Allergy. 2021;8(3):261-273. doi: 10.1007/s40521-021-00286-y. Epub 2021 Apr 16.

本文引用的文献

2
Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.
Leuk Lymphoma. 2018 Mar;59(3):625-632. doi: 10.1080/10428194.2017.1347931. Epub 2017 Jul 11.
4
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
N Engl J Med. 2015 Dec 17;373(25):2425-37. doi: 10.1056/NEJMoa1509388. Epub 2015 Dec 6.
5
Meta-analysis in clinical trials revisited.
Contemp Clin Trials. 2015 Nov;45(Pt A):139-45. doi: 10.1016/j.cct.2015.09.002. Epub 2015 Sep 4.
6
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31.
7
Infectious complications of chronic lymphocytic leukemia.
Semin Oncol. 2006 Apr;33(2):240-9. doi: 10.1053/j.seminoncol.2005.12.013.
8
Immune defects in patients with chronic lymphocytic leukemia.
Cancer Immunol Immunother. 2006 Feb;55(2):197-209. doi: 10.1007/s00262-005-0015-8. Epub 2005 Jul 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验